Thoracic epidural spinal cord stimulation to reduce freezing of gait in advanced Parkinson's disease
Official title: Application of Thoracic Epidural Spinal Cord Stimulation (SCS) for Managing Freezing of Gait (FOG) in Patients With Advanced Parkinson's Disease
Run by National Taiwan University Hospital · NCT06630702 · Data updated 2026-11-12
This study will try temporary thoracic spinal cord stimulation to see if it helps people with advanced Parkinson's disease whose freezing of gait does not respond to medications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 85 Years |
| Sex | All |
| Enrollment | 5 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Hsinchu, Hsinchu City) |
| Status | Recruiting |
| Started | September 20, 2024 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | November 20, 2025 |
| Trial ID | NCT06630702 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are 40–85-year-old patients with primary Parkinson's disease of more than five years who have freezing of gait that does not respond to medications and no secondary gait problems or spinal conditions that would block electrode placement.
✕Probably not a fit
Patients with atypical Parkinsonism, medication-controlled freezing of gait, spinal cord injuries, significant spinal stenosis or myelopathy at the implantation site, prior surgery or infection near the target area, or other major comorbidities are unlikely to benefit or may be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Investigators will place temporary, minimally invasive thoracic epidural stimulation electrodes and test different stimulation settings to see if gait stability and freezing episodes improve. The trial enrolls people aged 40–85 with primary Parkinson's disease for more than five years who have medication-refractory freezing of gait and no other secondary gait disorders. Outcomes will include measures of gait, freezing frequency, fall risk, and safety during and after temporary stimulation. The procedures are performed at a single center (National Taiwan University Hospital Hsin-Chu Branch) with exclusions for spinal canal stenosis, prior surgery or infection near the implantation site, atypical Parkinsonism, and spinal cord injury.
Why it matters
Potential benefit: If successful, temporary thoracic epidural SCS could improve walking stability and reduce falls in people with medication-refractory freezing of gait.
How similar studies have gone: Small case series and preliminary reports have shown gait and symptom improvements after spinal cord stimulation in Parkinson's patients, but the approach remains experimental and not yet widely validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age:40-85 years old. * Patients with primary Parkinson\'s disease who have been diagnosed by a movement disorder specialist for more than 5 years. Although they have a clear response to drugs, they have a frozen gait that cannot be controlled by drugs. Lower limb pain may be present with or without Parkinson\'s non-motor symptoms. * No other secondary gait problems. Exclusion Criteria: * Atypical Parkinson's disease. * Patients with spinal cord injuries. * Medication-controlled frozen gait. * It is expected that there are lesions near the implantation area causing spinal canal stenosis or myelopathy (can be ruled out by MRI). * It is expected that the implantation area has undergone previous surgery or there is infection near the implantation area, which may affect the success rate of implantation or increase concerns about complications (such as severe extraspinal adhesion, or spinal cord damage in previous surgeries). * People with abnormal coagulation function (such as hemophilia patients) or those who have been controlled by long-term use of antithrombotic drugs and cannot stop taking them in a short period of time. * CDR (Clinical Dementia Rating Scale) ≧2. 8. Those who are allergic to developer.
Where it's running
-
National Taiwan University Hospital Hsin-Chu Branch
Hsinchu, Hsinchu City, Taiwan Recruiting
Study contacts
- Study coordinator: Kai-Hsiang Chen, M.D.
- Email: stanleychen1230@gmail.com
- Phone: +886-3-5326151
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Decoding brain signals and DBS settings for freezing of gait in Parkinson’s
This study tests how brain activity and different DBS settings affect freezing of gait and balance in people with Parkinson’s who already have a Medtronic Percept DBS device.
-
Remote mental practice to help with freezing of gait in Parkinson's disease
This study is testing if a combination of mental exercises and physical practice can help people with Parkinson's disease who struggle with freezing while walking.
-
Percept recordings of brain activity during freezing of gait in Parkinson's disease
This research will use the Medtronic Percept DBS device to test whether brain electrical patterns differ during walking, movement transitions, and freezing in people with Parkinson's disease who do and do not experience freezing of gait.
-
Using deep brain stimulation and levodopa to improve walking in Parkinson's patients
This study is testing whether increasing deep brain stimulation or giving a higher dose of levodopa helps people with Parkinson's disease walk better and reduces freezing episodes.
-
CereGate Therapy for Freezing of Gait in Parkinson's Disease
This study is testing if CereGate therapy can help people with Parkinson's Disease who have freezing of gait feel more mobile and improve their movement after having deep brain stimulation.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.